Literature DB >> 11526504

hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors.

S Siegrist1, C Féral, M Chami, B Solhonne, M G Mattéi, E Rajpert-De Meyts, G Guellaën, F Bulle.   

Abstract

By systematic analysis of a human testis library, we have isolated the hH-Rev107-3 cDNA, identical to hH-Rev107-1 cDNA, which was previously described as a class II tumor suppressor gene. In this study, two transcripts (1 and 0.8 kb) were detected by Northern blot in all human tissues, excepted in thymus. The strongest expression was found in testis, skeletal muscle and heart. These two mRNA are probably transcribed from only one gene that we mapped to the q12-q13 region of the chromosome 11. In human testis, hH-Rev107 gene expression was localized, by in situ hybridization, within the round spermatids. To investigate a possible role for hH-Rev107 protein in testicular malignant growth, we examined the expression of this gene in germ cell tumors. A strong hH-Rev107 gene expression was observed in normal testis as well as in samples with preinvasive carcinoma in situ but was completely absent in overt tumors, both seminomas and non-seminomas. By in situ hybridization, CIS was found hH-Rev107 positive and tumor negative. A semi-quantitative assessment of hH-Rev107 mRNA level in testicular germ cell tumors, by RT-PCR, exhibited a ninefold decrease in the gene expression. No gross structural aberrations of hH-Rev107 gene were detected in these human primary tumors. The results suggest that down-regulation of hH-Rev107 may be associated with invasive progression of testicular germ cell tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526504      PMCID: PMC1865474          DOI: 10.1038/sj.onc.1204658

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

Review 1.  Post-transcriptional control of gene expression during spermatogenesis.

Authors:  R E Braun
Journal:  Semin Cell Dev Biol       Date:  1998-08       Impact factor: 7.727

Review 2.  Molecular mechanisms of male germ cell differentiation.

Authors:  N B Hecht
Journal:  Bioessays       Date:  1998-07       Impact factor: 4.345

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

Review 5.  Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia.

Authors:  E Rajpert-De Meyts; N Jørgensen; K Brøndum-Nielsen; J Müller; N E Skakkebaek
Journal:  APMIS       Date:  1998-01       Impact factor: 3.205

6.  Identification of a cat eye syndrome using DNA sequence dosage analysis.

Authors:  F Bulle; J Lespinasse; A Pawlak; E Vadot; J Sastre; B Noël; G Guellaen
Journal:  Ann Genet       Date:  1996

7.  Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12.

Authors:  K Husmann; C Sers; E Fietze; A Mincheva; P Lichter; R Schäfer
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

8.  Human testis specifically expresses a homologue of the rodent T lymphocytes RT6 mRNA.

Authors:  I Lévy; Y Q Wu; N Roeckel; F Bulle; A Pawlak; S Siegrist; M G Mattéi; G Guellaën
Journal:  FEBS Lett       Date:  1996-03-18       Impact factor: 4.124

9.  Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors.

Authors:  C Sers; U Emmenegger; K Husmann; K Bucher; A C Andres; R Schäfer
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

10.  High accumulation of components of the RNA polymerase II transcription machinery in rodent spermatids.

Authors:  E E Schmidt; U Schibler
Journal:  Development       Date:  1995-08       Impact factor: 6.868

View more
  6 in total

1.  High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer.

Authors:  Xueli Yang; Zhengquan Zhang; Xiaoqing Jia; Yanqin Zhang; Tianyang Mu; Bingzheng Zhou; Lin Li; Deyuan Fu; Xin Hu; Shunbin Xiong
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Intra-individual Genomic Variation Analysis in Tissues (Blood vs. Testis) Through SNP Microarray: A Case Report of Two Patients with Idiopathic Sertoli Cell Only Syndrome (SCOS).

Authors:  Aiyush Sharma; Ashutosh Halder; Seema Kaushal; Manish Jain
Journal:  J Reprod Infertil       Date:  2020 Oct-Dec

3.  Structure/function relationships of adipose phospholipase A2 containing a cys-his-his catalytic triad.

Authors:  Xiao-Yan Pang; Jian Cao; Linsee Addington; Scott Lovell; Kevin P Battaile; Na Zhang; J L Uma Maheswar Rao; Edward A Dennis; Alexander R Moise
Journal:  J Biol Chem       Date:  2012-08-25       Impact factor: 5.157

4.  PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.

Authors:  Shoulei Liang; Zhiwu Ren; Xiuxin Han; Jilong Yang; Luling Shan; Lin Li; Binying Wang; Qianyi Zhang; Tianyang Mu; Kexin Chen; Shunbin Xiong; Guowen Wang
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

5.  H-rev107 regulates prostaglandin D2 synthase-mediated suppression of cellular invasion in testicular cancer cells.

Authors:  Rong-Yaun Shyu; Chang-Chieh Wu; Chun-Hua Wang; Tzung-Chieh Tsai; Lu-Kai Wang; Mao-Liang Chen; Shun-Yuan Jiang; Fu-Ming Tsai
Journal:  J Biomed Sci       Date:  2013-05-20       Impact factor: 8.410

6.  RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma.

Authors:  R-Y Shyu; S-Y Jiang; J-M Chou; Y-L Shih; M-S Lee; J-C Yu; P-C Chao; Y-J Hsu; S-W Jao
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.